NYSE · AMTD

AMTD IDEA Group American , each representing six (6)

$0.77 -$0.03 (-3.85%) 1D Market open

Key Metrics

$75.75M
Market cap
P/E · TTM
Revenue · TTM
Net income
EPS · TTM
Dividend yield
Free cash flow $17.09M
Beta · 1Y 0.13
EBITDA · TTM
Gross margin

The Story So Far

LAST 6 MONTHS PRIMARY SOURCES ONLY
  • Jul 27
    From its Mar 13 high, the share price fell 28%.

    Peak close $1.06 on Mar 13; trough close $0.77 on Jul 27. The drawdown is the fact — the chapters around it are the context.

    RECEIPT: PRICE SERIES, PEAK-TO-TROUGH -28%
  • Jul 23
    The stock moved -8.4% in a single session.

    Sessions this size usually pair with a chapter above or below — a filing, a headline, or the whole cohort moving together.

    RECEIPT: DAILY BAR, Jul 23
  • Jul 20
    The stock moved -12.9% in a single session.

    Sessions this size usually pair with a chapter above or below — a filing, a headline, or the whole cohort moving together.

    RECEIPT: DAILY BAR, Jul 20
  • Jul 16
    Money rotated out of high-beta cohorts market-wide.

    High-beta names lagged the blue-chips by 18.6 points over ten sessions around this date. Stocks in that cohort weren't falling alone — they fell together.

    RECEIPT: ROTATION GAUGE, LIVE

The story updates itself as events post · The wolf reports; you decide

Snapshot

Market cap$75.75M
Enterprise value$316.82M
Shares outstanding94.9M
52-wk range$0.75 – $1.65
Avg volume · 20D218.0K
Net cash −$241.07M
Book value / share$14.49
ExchangeNYSE
About AMTD IDEA Group American , each representing six (6)
IPO dateAug 5, 2019
Employees166

AMTD IDEA Group is a diversified institution and digital solutions conglomerate group, connecting companies and investors with world-wide markets.

Wolf Grade COMING SOON

The wolf is in training. Composite grades vs sector — profitability, health, value, momentum — arrive with the percentile engine. Methodology will be public.

Valuation

P/E
P/S
P/FCF4.43
EV/EBITDA
EV/Sales
Graham №

Profitability

Gross
Operating
Net
FCF
ROE / ROIC — · —

Financial Health

Current ratio8.83
Quick ratio
Debt / equity0.21
Debt / EBITDA
Net cash −$241.07M
Working capital$1.27B

Cash Flow · TTM

Operating CF $17.84M
Capex −$746.00K
Free cash flow $17.09M
Buybacks
Dividends paid
Shareholder yield

Piotroski F-Score

5 / 9
Middling fundamentals · 5 of 9 signals passing

Altman Z-Score

Insufficient balance-sheet inputs

Graham Number vs Price

Requires positive earnings and book value
Fundamentals through 2025-12-31 · computed by TickerWolf from SEC filings